Neuropace Inc at RBC Capital Markets Global Healthcare Conference Transcript
From the company is Mike Favet, Chief Executive Officer. And we're sorry, Rebecca couldn't be here today, the Chief Financial Officer.
Just by way of background, NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available brain responsive platform that delivers personalized real-time treatment at the seizure source.
Mike, thank you so much for being here today. And again, the floor is yours.
Rhea, thank you. Is the microphone working? It sounds like it? Thank you for the opportunity to be here. I was sharing earlier that this is my first in-person investor conference in over two years. So very glad to be back to doing some of these in person, and thanks for the introduction.
So standard
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |